Items related to When Progress Fails to Materialize: When new cancer...
When Progress Fails to Materialize: When new cancer drugs become available and who receives them - Softcover
Synopsis
This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available. It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies. The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today. Bremen University Press has published over 5,000 specialist books in various languages since 2005. September 2025
"synopsis" may belong to another edition of this title.
Search results for When Progress Fails to Materialize: When new cancer...
Stock Image
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Seller: California Books, Miami, FL, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # I-9783691733884
Seller Image
When Progress Fails to Materialize
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: New. Seller Inventory # LU-9783691733884
Buy New
£ 22.33
Free Shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Stock Image
When Progress Fails to Materialize
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # L2-9783691733884
Stock Image
When Progress Fails to Materialize
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # L2-9783691733884
Buy New
£ 21.28
£ 3.29 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Stock Image
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandSeller: Majestic Books, Hounslow, United Kingdom
Seller rating 4 out of 5 stars
Condition: New. Print on Demand. Seller Inventory # 408252279
Buy New
£ 26.32
£ 6.50 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: 4 available
Stock Image
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandSeller: Books Puddle, New York, NY, U.S.A.
Seller rating 4 out of 5 stars
Condition: New. Print on Demand. Seller Inventory # 26404934824
Stock Image
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandSeller: Biblios, Frankfurt am main, HESSE, Germany
Seller rating 4 out of 5 stars
Condition: New. PRINT ON DEMAND. Seller Inventory # 18404934818
Stock Image
When Progress Fails to Materialize
Published by
Bremen University Press Sep 2025, 2025
ISBN 10: 3691733883
ISBN 13: 9783691733884
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 116 pp. Englisch. Seller Inventory # 9783691733884
Stock Image
When Progress Fails to Materialize (Paperback)
Print on DemandSeller: CitiRetail, Stevenage, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: new. Paperback. This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available. It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies. The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today. Bremen University Press has published over 5,000 specialist books in various languages since 2005. September 2025 This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9783691733884
Buy New
£ 24.49
£ 37 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: 1 available
Seller Image
When Progress Fails to Materialize
Published by
Bremen University Press Sep 2025, 2025
ISBN 10: 3691733883
ISBN 13: 9783691733884
New
Taschenbuch
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available.It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies.The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today.Bremen University Press has published over 5,000 specialist books in various languages since 2005.September 2025Books on Demand GmbH, Überseering 33, 22297 Hamburg 116 pp. Englisch. Seller Inventory # 9783691733884